Skip to main content

. 1983 Dec 17;287(6408):1845. doi: 10.1136/bmj.287.6408.1845

Impaired elimination of metronidazole in decompensated chronic liver disease.

G Farrell, L Zaluzny, J Baird-Lambert, M Cvejic, N Buchanan

PMCID: PMC1550041 PMID: 6423039

1845

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Daneshmend T. K., Homeida M., Kaye C. M., Elamin A. A., Roberts C. J. Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis. Gut. 1982 Oct;23(10):807–813. doi: 10.1136/gut.23.10.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
Farrell G. C., Cooksley W. G., Hart P., Powell L. W. Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism. Gastroenterology. 1978 Oct;75(4):580–588. [PubMed] [Google Scholar]
Ioannides L., Somogyi A., Spicer J., Heinzow B., Tong N., Franklin C., McLean A. Rectal administration of metronidazole provides therapeutic plasma levels in postoperative patients. N Engl J Med. 1981 Dec 24;305(26):1569–1570. doi: 10.1056/NEJM198112243052607. [DOI] [PubMed] [Google Scholar]
Koch-Weser J., Goldman P. Drug therapy: metronidazole. N Engl J Med. 1980 Nov 20;303(21):1212–1218. doi: 10.1056/NEJM198011203032106. [DOI] [PubMed] [Google Scholar]
Shargel L., Cheung W. M., Yu A. B. High-pressure liquid chromatographic analysis of antipyrine in small plasma samples. J Pharm Sci. 1979 Aug;68(8):1052–1054. doi: 10.1002/jps.2600680835. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES